BVI Medical completes a $1 billion strategic capital raise

News
Article

The capital raise was completed in partnership with global alternative asset management firm TPH.

Graphic of stock market and coins Image credit: AdobeStock/Kiattisak

Image credit: AdobeStock/Kiattisak

Global ophthalmic device company BVI Medical has announced the completion of its $1 billion strategic capital raise in partnership with global alternative asset management firm TPH. The investment fully refinanced BVI’s existing debt and added new equity from both TPG and new investors.1 The company plans to continue substantial growth in its portfolio of product offerings in light of the investment, according to a news release.

“This investment marks a pivotal moment for BVI as we scale our capabilities to meet the rising demand for advanced ophthalmic solutions,” said Shervin Korangy, president and CEO of BVI, in the release. “We are redefining the future of eye surgery and changing the competitive landscape by driving the launch of breakthrough technologies that will empower surgeons worldwide.”

Of recent note, BVI expanded its IOL manufacturing to Europe in order to meet global product demand, introduced new product lines including SERENITY and SERENITY Toric premium monofocal IOLs,2 and has engaged in a number of strategic acquisitions. Additionally, the company launched an education platform for ophthalmologists earlier this year, which allows physicians to connect across specialties to share insights and address complex cases.3

“TPG is proud to continue our partnership with BVI as it works to scale its global impact in ophthalmic care,” said Kendall Garrison, Partner at TPG. “The company has strengthened its market position while advancing patient care worldwide and this investment will further drive innovation and expansion. We look forward to supporting BVI’s continued success,” added John Schilling, MD, Co-Managing Partner at TPG Capital.

References:
  1. BVI Medical secures strategic capital raise to fuel global growth and innovation. News release. Businesswire. March 10, 2025. Accessed March 12, 2025. https://www.businesswire.com/news/home/20250306731225/en/BVI-Medical-Secures-Strategic-Capital-Raise-to-Fuel-Global-Growth-and-Innovation
  2. Joy J. BVI to launch new SERENITY and SERENITY Toric monofocal IOLs. Optometry Times. September 5, 2024. Accessed March 12, 2025. https://www.optometrytimes.com/view/bvi-to-launch-new-serenity-and-serenity-toric-monofocal-iols
  3. BVI Medical launches educational platform for ophthalmology professionals. News release. News release. BVI Medical. January 31, 2025. Accessed March 12, 2025. https://www.bvimedical.com/us/bvi-medical-launches-educational-platform-for-ophthalmology-professionals/
Recent Videos
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Related Content
Physician pointing to renal diagram Image credit: AdobeStock/Phushutter

Renal dysfunction may affect intravitreal conbercept effectiveness in DME treatment

Lynda Charters
March 14th 2025
Article
Debunking common ortho-k myths

Debunking common ortho-k myths

Kassi Jackson Filkins, Editor;Chandra Mickles, OD, MS, FAAO, FSLS
October 6th 2022
Podcast
Doctor with referral note Image credit: AdobeStock/thodonal

New study finds low diagnostic rates for patients with glaucoma referrals

Jordana Joy, Associate Editor
March 13th 2025
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Jackson Filkins, Editor
September 15th 2022
Podcast
Businessmen shaking hands with digital graphic overlay Image credit: AdobeStock/Vittaya_25

Topcon Healthcare, RadiusXR, and Glaukos enter into a collaboration

Jordana Joy, Associate Editor
March 12th 2025
Article
Closeup of eye Image credit: AdobeStock/VictoriaKey

Eye-opening effects caused by modified transconjunctival lower blepharoplasty

Lynda Charters
March 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.